Frequent NF2 Inactivation in Mesothelioma: How Can We Treat Mesothelioma with Targeted Therapies for Molecular Aberrations?
Crossref DOI link: https://doi.org/10.1007/978-981-15-9158-7_14
Published Online: 2021-02-06
Published Print: 2021
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sekido, Yoshitaka
Text and Data Mining valid from 2021-01-01
Version of Record valid from 2021-01-01
Chapter History
First Online: 6 February 2021